SEPN
Septerna, Inc. Common Stock
NASDAQ: SEPN · HEALTHCARE · BIOTECHNOLOGY
$23.76
+1.32% today
Updated 2026-04-30
Market cap
$1.05B
P/E ratio
—
P/S ratio
22.92x
EPS (TTM)
$-1.10
Dividend yield
—
52W range
$6 – $33
Volume
0.3M
Septerna, Inc. Common Stock (SEPN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0.00 | $151000.00 | $1.07M | $45.95M |
| Revenue growth (YoY) | — | — | +611.9% | +4174.5% |
| Cost of revenue | — | — | — | $1.60M |
| Gross profit | — | $151000.00 | $1.07M | $45.95M |
| Gross margin | — | 100.0% | 100.0% | 100.0% |
| R&D | $22.04M | $35.98M | $65.34M | $97.58M |
| SG&A | $5.92M | $9.72M | $16.56M | $29.16M |
| Operating income | $-27.97M | $2.08M | $-80.82M | $-80.80M |
| Operating margin | — | 1374.2% | -7518.4% | -175.8% |
| EBITDA | $-27.39M | $-44.70M | $-79.42M | $-79.19M |
| EBITDA margin | — | -29604.0% | -7388.1% | -172.3% |
| EBIT | $-27.97M | $-45.55M | $-80.82M | $-80.80M |
| Interest expense | — | — | — | — |
| Income tax | — | $691000.00 | $-498000.00 | — |
| Effective tax rate | 0.0% | 14.2% | 0.7% | 0.0% |
| Net income | $-27.68M | $4.18M | $-71.80M | $-48.88M |
| Net income growth (YoY) | — | +115.1% | -1817.7% | +31.9% |
| Profit margin | — | 2768.2% | -6678.9% | -106.4% |